Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.57 |
| ▸ | AGXT | P21549 | 2/20 | 0.57 |
| ▸ | CA1 | P00915 | 2/20 | 0.51 |
| ▸ | CA2 | P00918 | 2/20 | 0.51 |
| ▸ | APP | P05067 | 7/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5567139 | 0.86 | CA1 (0.45) | IDO1AGXTCA1CA2APP | |
| SCHEMBL34413 | 0.86 | IDO1 (0.67) | IDO1AGXTCA1CA2APP | |
| SCHEMBL1475481 | 0.84 | IDO1 (0.64) | IDO1AGXTCA1CA2APP | |
| Potassium SCHEMBL1477050 | 0.84 | IDO1 (0.64) | IDO1AGXTCA1CA2APP | |
| SCHEMBL1838338 | 0.83 | TDP1 (0.54) | IDO1AGXTCA1CA2APP | |
| SCHEMBL8499580 | 0.82 | IDO1 (0.61) | IDO1AGXTCA1CA2APP | |
| SCHEMBL27455063 | 0.81 | IDO1 (0.67) | IDO1AGXTCA1CA2APP | |
| SCHEMBL9022493 | 0.80 | L3MBTL1 (0.59) | IDO1AGXTCA1CA2APP | |
| SCHEMBL52777 | 0.80 | IDO1 (0.59) | IDO1AGXTCA1CA2APP | |
| SCHEMBL11132720 | 0.80 | LTA4H (0.65) | IDO1AGXTCA1CA2APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3994939-A | BACTERICIDES | PFIZER INC. (US) | 1976-11-30 | — | — | US | claimed |
| WO-2023189817-A1 | ONIUM SALT, ONIUM SALT COMPOSITION, LIQUID COMPOSITION CONTAINING ONIUM SALT AND POLYSACCHARIDE AND PRODUCTION METHOD THEREOF, AND METHOD FOR RECOVERING POLYSACCHARIDE | 広栄化学株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-2492033-B1 | METAL NANOPARTICLE CONTAINING COMPLEX, FLUID DISPERSION THEREOF AND PRODUCTION METHODS FOR METAL NANOPARTICLE CONTAINING COMPLEX AND FLUID DISPERSION THEREOF | DAINIPPON INK & CHEMICALS (JP) | 2017-03-08 | — | — | EP | disclosed |
| US-8388870-B2 | Metal-nanoparticle-containing composite, dispersion liquid thereof, and methods for producing the metal-nanoparticle-containing composite and the dispersion liquid | DIC CORPORATION (JP) | 2013-03-05 | — | — | US | disclosed |
| US-20120280186-A1 | METAL-NANOPARTICLE-CONTAINING COMPOSITE, DISPERSION LIQUID THEREOF, AND METHODS FOR PRODUCING THE METAL-NANOPARTICLE-CONTAINING COMPOSITE AND THE DISPERSION LIQUID | DIC CORPORATION (JP) | 2012-11-08 | — | — | US | disclosed |
| EP-2492033-A1 | METAL NANOPARTICLE CONTAINING COMPLEX, FLUID DISPERSION THEREOF AND PRODUCTION METHODS FOR METAL NANOPARTICLE CONTAINING COMPLEX AND FLUID DISPERSION THEREOF | DIC Corporation (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-8163753-B2 | 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| US-20100081693-A1 | THIADIAZOLE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-01 | — | — | US | disclosed |
| EP-2061789-A2 | THIADIAZOLE COMPOUND AND USE THEREOF | Sumitomo Chemical Company, Limited (JP) | 2009-05-27 | — | — | EP | disclosed |
| EP-1678185-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMA CO LTD (JP) | 2008-10-08 | — | — | EP | disclosed |
| EP-0464408-B1 | Process for preparing star compounds | SEKISUI CHEMICAL CO LTD (JP) | 1994-01-12 | — | — | EP | disclosed |
| US-5266468-A | Process for preparing β-hydroxy-α amino acids | UNIVERSITY OF NOTRE DAME DU LAC (US) | 1993-11-30 | — | — | US | disclosed |
| EP-0500853-A1 | PHENYLETHANOLAMINES, DRUGS CONTAINING THESE COMPOUNDS, AND A METHOD OF PREPARING THEM. | THOMAE GMBH DR K (DE) | 1992-09-02 | — | — | EP | disclosed |
| US-5102966-A | Addition polymerization of unsaturated ethers using an unsaturated alkenyl polyether adduct as initiator and a cation-donating compound | SEKISUI CHEMICAL CO., LTD. (JP) | 1992-04-07 | — | — | US | disclosed |
| WO-1992004316-A1 | PHENYLETHANOLAMINES, DRUGS CONTAINING THESE COMPOUNDS, AND A METHOD OF PREPARING THEM | DR. KARL THOMAE GMBH (DE) | 1992-03-19 | — | — | WO | disclosed |
| CN-1058046-A | The method for preparing beta-hydroxy-a-amino acid | UNIV NOTRE DAME DU LAC (US) | 1992-01-22 | — | — | CN | disclosed |
| EP-0464408-A1 | Process for preparing star compounds | SEKISUI CHEMICAL CO., LTD. (JP) | 1992-01-08 | — | — | EP | disclosed |
| EP-0460883-A2 | Process for beta-hydroxy-alpha-amino acids | THE UNIVERSITY OF NOTRE DAME DU LAC (US) | 1991-12-11 | — | — | EP | disclosed |
| US-4820815-A | USEFUL AS ANTIBACTERIALS OR TO FORM FUSED BICYCLIC B-LACTAM ANTIBIOTICS LIKE CARBAPENEMS | UNIVERSITY OF NOTRE DAME DU LAC (US) | 1989-04-11 | — | — | US | disclosed |
| EP-0306266-A1 | Azetidinone n-phosphonomethyl esters | THE UNIVERSITY OF NOTRE DAME DU LAC (US) | 1989-03-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081693-A1 | THIADIAZOLE COMPOUND AND USE THEREOF | NR2C2, NR4A3, NR0B2 | IDO1 1716/4885AGXT 3155/4885CA1 4105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.